BE905815A - Flavivirus antigeen. - Google Patents

Flavivirus antigeen. Download PDF

Info

Publication number
BE905815A
BE905815A BE2/61092A BE2061092A BE905815A BE 905815 A BE905815 A BE 905815A BE 2/61092 A BE2/61092 A BE 2/61092A BE 2061092 A BE2061092 A BE 2061092A BE 905815 A BE905815 A BE 905815A
Authority
BE
Belgium
Prior art keywords
gly
ala
ser
leu
thr
Prior art date
Application number
BE2/61092A
Other languages
English (en)
Dutch (nl)
Original Assignee
Univ Osaka Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka Res Found filed Critical Univ Osaka Res Found
Publication of BE905815A publication Critical patent/BE905815A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE2/61092A 1986-06-05 1986-11-26 Flavivirus antigeen. BE905815A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61131208A JPH0768267B2 (ja) 1986-06-05 1986-06-05 フラビウイルス抗原

Publications (1)

Publication Number Publication Date
BE905815A true BE905815A (nl) 1987-03-16

Family

ID=15052566

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2/61092A BE905815A (nl) 1986-06-05 1986-11-26 Flavivirus antigeen.

Country Status (9)

Country Link
US (1) US4810492A (cg-RX-API-DMAC10.html)
JP (1) JPH0768267B2 (cg-RX-API-DMAC10.html)
BE (1) BE905815A (cg-RX-API-DMAC10.html)
CA (1) CA1270780A (cg-RX-API-DMAC10.html)
DE (1) DE3641040A1 (cg-RX-API-DMAC10.html)
FR (1) FR2599626B1 (cg-RX-API-DMAC10.html)
GB (1) GB2191201B (cg-RX-API-DMAC10.html)
IT (1) IT1198289B (cg-RX-API-DMAC10.html)
NL (1) NL189207C (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620459A1 (fr) * 1987-09-16 1989-03-17 Nippon Zeon Co Virus recombinant de la vaccine

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2511494B2 (ja) * 1988-05-12 1996-06-26 善治 松浦 日本脳炎ウイルス表面抗原蛋白質の製造法
US6676936B1 (en) 1988-07-14 2004-01-13 The United States Of America As Represented By The Department Of Health And Human Services. Chimeric and/or growth-restricted flaviviruses
US6184024B1 (en) 1988-07-14 2001-02-06 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and/or growth-restricted flaviviruses
FR2654113A1 (fr) * 1989-11-09 1991-05-10 Pasteur Institut Procede de diagnostic de virus appartenant a la famille des flaviviridae.
SE470074B (sv) * 1990-08-16 1993-11-01 Replico Medical Ab Förfarande för diagnos av picorna- och/eller flavivirusinfektion, peptider, diagnostiska antigener och vaccinkomposition med dessa peptider
US5494671A (en) * 1990-08-27 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
US5874563A (en) * 1994-05-20 1999-02-23 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
US5824507A (en) * 1994-05-20 1998-10-20 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
EP0836482B1 (en) * 1995-05-24 2002-11-13 Hawaii Biotechnology Group, Inc. Subunit vaccine against flavivirus infection
EP1084252B1 (en) 1998-06-04 2006-12-27 The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services Nucleic acid vaccines for prevention of flavivirus infection
US7227011B2 (en) * 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
EP1263965B1 (en) 2000-02-16 2011-09-28 The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services Avirulent, immunogenic flavivirus chimeras
WO2004016586A2 (en) * 2002-08-16 2004-02-26 Board Of Regents The University Of Texas System Compositions and methods related to flavivirus envelope protein domain iii antigens
EP1558276B1 (en) * 2002-11-08 2012-07-25 The Administrators of the Tulane Educational Fund Flaviviris fusion inhibitors
CA2768997C (en) 2009-07-31 2017-09-12 Xcellerex, Inc. High yield yellow fever virus strain with increased propagation in cells
FI3539565T3 (fi) 2013-03-15 2023-04-19 Takeda Vaccines Inc Koostumuksia ja menetelmiä dengue-viruksen kimeerisille rakenteille rokotteissa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (cg-RX-API-DMAC10.html) * 1981-08-04 1984-08-04 Univ California
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
JPH01501203A (ja) * 1986-10-27 1989-04-27 フォーニアー，モーリル・ジェイ 日本脳炎ウイルス及び類似ウイルスの診断及びワクチン

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620459A1 (fr) * 1987-09-16 1989-03-17 Nippon Zeon Co Virus recombinant de la vaccine

Also Published As

Publication number Publication date
IT1198289B (it) 1988-12-21
GB8628072D0 (en) 1986-12-31
CA1270780A (en) 1990-06-26
NL189207C (nl) 1993-02-01
NL8603017A (nl) 1988-01-04
GB2191201B (en) 1991-01-23
NL189207B (nl) 1992-09-01
DE3641040C2 (cg-RX-API-DMAC10.html) 1989-10-26
US4810492A (en) 1989-03-07
DE3641040A1 (de) 1987-12-10
JPH0768267B2 (ja) 1995-07-26
FR2599626B1 (fr) 1992-02-28
JPS62286930A (ja) 1987-12-12
GB2191201A (en) 1987-12-09
FR2599626A1 (fr) 1987-12-11
IT8622505A0 (it) 1986-11-28

Similar Documents

Publication Publication Date Title
CA1341410C (en) Recombinant acquired immune deficiency syndrome (aids) viral envelope protein and method of testing for aids
BE905815A (nl) Flavivirus antigeen.
CA2405438C (en) Hepatitis b core antigen fusion proteins
NO313917B1 (no) Antigen-presenterende kapsid med fusert MS2-kappeprotein
US20110150920A1 (en) Allergy Vaccines Containing Hybrid Polypeptides
EP4588942A1 (en) Truncated respiratory syncytial virus f protein and use thereof
IL102092A (en) Use of recombinant hiv envelope protein in medicament for treating hiv and therapeutic composition containing the agglomerated protein
CN112552413B (zh) 新型冠状病毒重组蛋白亚单位疫苗
JPH09502353A (ja) プラスモジウム・ビバックスおよびプラスモジウム・ファルシパルム赤血球結合蛋白質からの結合領域
JPH01500161A (ja) Ａｉｄｓの原因ウィルスの糖蛋白質、該糖蛋白質の製造方法及びワクチン
JPH01501357A (ja) ヒト呼吸器系ウイルス用ワクチン
JPH05509226A (ja) Ｅｈｖ―４糖蛋白質ワクチン
CA2204511A1 (fr) Production de peptides recombinants, analogues de peptides naturels hydrophobes
JP3262787B2 (ja) 豚コレラウイルスワクチン
CN115161344A (zh) 一种针对呼吸道合胞病毒感染的疫苗的制备方法
KR102332725B1 (ko) 오량체 기반 재조합 단백질 백신 플랫폼 및 이를 발현하는 시스템
JP3135060B2 (ja) ヘモフィルスインフルエンザｂ型菌の外皮膜タンパク質Ｐ２の部分断片を用いた接合体
US5486473A (en) A DNA coding for a Flavivirus antigen
AU614535B2 (en) Recombinant htlv-iii proteins and uses thereof
KR940005586B1 (ko) 플라비 비루스 항원
KR0178110B1 (ko) 대장균에서 발현된 인간유래 한탄바이러스의 뉴클레오캡시드 단백질을 이용한 백신
JPS6322098A (ja) Ｂ型肝炎ウイルス抗原とその製造法
JPH08269092A (ja) 大腸菌組換え狂犬病ワクチン
MXPA01010481A (es) Acidos nucleicos y polipeptidos de lisavirus quimerico.
TW200844227A (en) Recombinant viral proteins and particles

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF

Effective date: 20011130